16-71626291-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_052858.6(MARVELD3):c.62G>T(p.Arg21Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000136 in 1,541,752 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_052858.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MARVELD3 | NM_052858.6 | c.62G>T | p.Arg21Leu | missense_variant | 1/3 | ENST00000268485.8 | |
MARVELD3 | NM_001017967.4 | c.62G>T | p.Arg21Leu | missense_variant | 1/3 | ||
MARVELD3 | NM_001271329.2 | c.62G>T | p.Arg21Leu | missense_variant | 1/3 | ||
MARVELD3 | XM_011523449.4 | c.62G>T | p.Arg21Leu | missense_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MARVELD3 | ENST00000268485.8 | c.62G>T | p.Arg21Leu | missense_variant | 1/3 | 1 | NM_052858.6 | P2 | |
ENST00000562763.1 | n.219+307C>A | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000661 AC: 10AN: 151294Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000212 AC: 3AN: 141308Hom.: 0 AF XY: 0.0000131 AC XY: 1AN XY: 76272
GnomAD4 exome AF: 0.00000791 AC: 11AN: 1390338Hom.: 0 Cov.: 58 AF XY: 0.00000730 AC XY: 5AN XY: 684780
GnomAD4 genome AF: 0.0000660 AC: 10AN: 151414Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74048
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 24, 2023 | The c.62G>T (p.R21L) alteration is located in exon 1 (coding exon 1) of the MARVELD3 gene. This alteration results from a G to T substitution at nucleotide position 62, causing the arginine (R) at amino acid position 21 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at